Does ADEFOVIR DIPIVOXIL Cause Hepatocellular carcinoma? 70 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 70 reports of Hepatocellular carcinoma have been filed in association with ADEFOVIR DIPIVOXIL (Adefovir dipivoxil). This represents 3.3% of all adverse event reports for ADEFOVIR DIPIVOXIL.
70
Reports of Hepatocellular carcinoma with ADEFOVIR DIPIVOXIL
3.3%
of all ADEFOVIR DIPIVOXIL reports
23
Deaths
29
Hospitalizations
How Dangerous Is Hepatocellular carcinoma From ADEFOVIR DIPIVOXIL?
Of the 70 reports, 23 (32.9%) resulted in death, 29 (41.4%) required hospitalization, and 3 (4.3%) were considered life-threatening.
Is Hepatocellular carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADEFOVIR DIPIVOXIL. However, 70 reports have been filed with the FAERS database.
What Other Side Effects Does ADEFOVIR DIPIVOXIL Cause?
Drug resistance (417)
Osteomalacia (409)
Hypophosphataemia (368)
Fanconi syndrome acquired (304)
Osteoporosis (224)
Bone pain (213)
Renal impairment (203)
Drug ineffective (195)
Arthralgia (174)
Blood phosphorus decreased (150)
What Other Drugs Cause Hepatocellular carcinoma?
SORAFENIB (1,665)
RIBAVIRIN (1,046)
SOFOSBUVIR (877)
LEDIPASVIR\SOFOSBUVIR (640)
BEVACIZUMAB (532)
REGORAFENIB (470)
DACLATASVIR (419)
ATEZOLIZUMAB (342)
CABOZANTINIB S-MALATE (219)
TACROLIMUS (183)
Which ADEFOVIR DIPIVOXIL Alternatives Have Lower Hepatocellular carcinoma Risk?
ADEFOVIR DIPIVOXIL vs ADEMETIONINE
ADEFOVIR DIPIVOXIL vs ADENOSINE
ADEFOVIR DIPIVOXIL vs ADO-TRASTUZUMAB EMTANSINE
ADEFOVIR DIPIVOXIL vs ADRIAMYCIN
ADEFOVIR DIPIVOXIL vs ADUCANUMAB